Ihh Healthcare Berhad

WHO'M

Digital Profiler. Simply click the AI button

CUSIP

Y374AH103

SEDOL

B83X6P8

CIK

N/A

LEI:

FIGI: BBG0033XXWK8

IHH

Ihh Healthcare Berhad

GICS: - · Sector: - · Sub-Sector: -

PROFILER

NAME

Ihh Healthcare Berhad

ISIN

MYL5225OO007

TICKER

IHH

MIC

XKLS

REUTERS

BLOOMBERG

BUILD THEMEFOLIO SHARE IDEAS DISCUSS

LEVERAGE INVEST

Financial Intelligence

360°^iHub Crowd^iFeed ATH Tracker Index Tracker ETF TF Spicy² X-Billboard

FOR INVESTORS

FOR TRADERS

Securities Trading Warrants

GlobeNewswire is an important news source that provides investors with company-related information. In particular, it deals with events that may be relevant to the listing of companies or tradable financial instruments. You can access the complete overview of all reports via this link.

Wed, 29.05.2024

KUALA LUMPUR, Malaysia and SINGAPORE, May 29, 2024 (GLOBE NEWSWIRE) --

Q1 2024: Outstanding core performance

Research & Analysis

Wed, 15.05.2024

SINGAPORE, May 15, 2024 (GLOBE NEWSWIRE) -- IHH Healthcare, a world-leading integrated healthcare provider, has reinforced its position as Asia’s leading cancer care provider with the official opening of the Mount Elizabeth Proton Therapy Centre in Singapore.

Research & Analysis

We are different

OPEN FINANCIAL

DATA & KNOWLEDGE HUB

We make the difference

Information on product placements

Legend

SMART * AD

P R O D U C T S U G G E S T I O N S

First Name *

Last Name

Email *

Subject *

i.e Feature x is not working

Issue happened on *

This page

Other page

Bug Detail *

Please give us more detailed explanation of the issue

Steps to reproduce *

Specify the steps you've done before the issue happen

Actual Result *

What's the result of the issue?

Expected Result *

What do you expect to see?

Attachment

(Optional) You can send us a screenshot, word document, or a PDF explaining the issue

Please log in to your user account. This will allow us to contact you in case of any queries.

I would like to remain anonymous.

Ihh Healthcare Berhad

IHH reports highest ever quarterly revenue in Q1 2024, with double-digit growth across key metrics, on outstanding performance across all markets

IHH Spearheads Cancer Care Leadership in Asia With Official Launch of Region’s First Private Proton Therapy Centre

Newsletter